Home » Topics » Regulatory

Regulatory
RSS

Phase I study of pentosan polysulfate in cancer patients

Feb. 25, 1997

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Centocor seeks expansion of ReoPro indications

Feb. 21, 1997

Transdermal buspirone pivotal trials

Feb. 21, 1997

Schering-Plough seeks FDA approval for psoriasis treatment

Feb. 20, 1997

Antidepressant with minimal impact on sexual function introduced

Feb. 18, 1997

Immunomedics' LeukoScan approved for European market

Feb. 18, 1997

New dosage strengths of Coumadin available

Feb. 18, 1997

Japanese introduction for new formulation of epoetin alfa

Feb. 18, 1997

Harvard Scientific's impotence drug advances in European trials

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...